LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Revenue

LAVA Therapeutics had revenue of $4.99M in the twelve months ending June 30, 2025, down -32.55% year-over-year. In the year 2024, LAVA Therapeutics had annual revenue of $11.98M with 77.01% growth.

• Revenue (ttm): $4.99M
• Revenue Growth: -32.55%
• P/S Ratio: 8.24
• Revenue / Employee: $146,765
• Employees: 34
• Market Cap: 39.99M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.98M	5.21M	77.01%
Dec 31, 2023	6.77M	-12.62M	-65.09%
Dec 31, 2022	19.39M	14.04M	262.45%
Dec 31, 2021	5.35M	1.60M	42.78%
Dec 31, 2020	3.75M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.